Omega-3 polyunsaturated fatty acids/vitamin e Interactions
There are 267 drugs known to interact with omega-3 polyunsaturated fatty acids/vitamin e, along with 4 disease interactions. Of the total drug interactions, 1 is major, 180 are moderate, and 86 are minor.
- View all 267 medications that may interact with omega-3 polyunsaturated fatty acids/vitamin e
- View omega-3 polyunsaturated fatty acids/vitamin e disease interactions (4)
Most frequently checked interactions
View interaction reports for omega-3 polyunsaturated fatty acids / vitamin e and the medicines listed below.
- Aleve (naproxen)
- Aptiom (eslicarbazepine)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- CoQ10 (ubiquinone)
- Curcuplex-95 (turmeric)
- Depakote ER (divalproex sodium)
- Emgality (galcanezumab)
- Farxiga (dapagliflozin)
- Florastor (saccharomyces boulardii lyo)
- Iron Fumarate (ferrous fumarate)
- Iron Sulfate (ferrous sulfate)
- Jardiance (empagliflozin)
- L-Methyl-B6-B12 (multivitamin)
- L-Tyrosine (tyrosine)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Levemir (insulin detemir)
- Lexapro (escitalopram)
- Liletta (levonorgestrel)
- Magnesium Mineral Support (magnesium malate)
- Norwegian Cod Liver Oil With EPA and DHA (multivitamin)
- NP Thyroid (thyroid desiccated)
- Omega-3 Fish Oil (omega-3 polyunsaturated fatty acids)
- Ozempic (semaglutide)
- ProAir HFA (albuterol)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Omega-3 polyunsaturated fatty acids/vitamin e disease interactions
There are 4 disease interactions with omega-3 polyunsaturated fatty acids / vitamin e which include:
Report options
QR code containing a link to this page
More about omega-3 polyunsaturated fatty acids / vitamin e
- omega-3 polyunsaturated fatty acids/vitamin e consumer information
- Compare alternatives
- Side effects
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
